Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)

Disparities in uptake of direct-acting antiviral Therapy for Hepatitis C among people who inject drugs in a Canadian setting

(2019) M. Eugenia Socías et al.   LIVER INTERNATIONAL

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy

(2019) Matthew J. Akiyama et al.   ANNALS OF INTERNAL MEDICINE

Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs

(2019) Amanda J Wade et al.   CLINICAL INFECTIOUS DISEASES

The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

(2019) Adam Trickey et al.   Lancet Gastroenterology & Hepatology

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

(2019) Lars T. Fadnes et al.   BMC INFECTIOUS DISEASES

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

(2019) Behzad Hajarizadeh et al.   JOURNAL OF HEPATOLOGY

Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial

(2019) Sunil Suhas Solomon et al.   JOURNAL OF HEPATOLOGY

Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?

(2018) Rafael Dal-Ré et al.   BMC Medicine

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

(2018) Jason Grebely et al.   ADDICTION

HCV epidemiology in high-risk groups and the risk of reinfection

(2016) Håvard Midgard et al.   JOURNAL OF HEPATOLOGY

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013

(2016) Louisa Degenhardt et al.   LANCET INFECTIOUS DISEASES

Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study

(2016) Håvard Midgard et al.   PLoS One

Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study

(2013) Knut Boe Kielland et al.   JOURNAL OF HEPATOLOGY

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011

(2013) J. Iversen et al.   JOURNAL OF VIRAL HEPATITIS

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review

(2013) Viktor Mravcik et al.   Patient Preference and Adherence

All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study

(2012) Knut Boe Kielland et al.   JOURNAL OF HEPATOLOGY

Hepatitis C testing and treatment among active drug users in Amsterdam

(2010) Catharina E.A. Lindenburg et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis

(2010) Zhong-Hua Lin et al.   HEPATOLOGY